| |
|
|
|
DiaMedica Therapeutics Inc.  
|
|
2.92 0.03 (0.01%) |
09-16 10:41 |
|
Open: |
2.93 |
Pre close: |
2.89 |
Target:
|
4.04
|
|
High: |
2.94 |
Low: |
2.92 |
Resistance:
|
3.46
4.04
|
|
Volume: |
1,074 |
Market Cap: |
35M |
Support:
|
2.65
2.15
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.85
 |
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
2.73 |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
3.37  |
Stochastic Oscillator |
%K(14,3):
|
78.13 |
|
MA(250): |
4.22 |
%D(3): |
73.15 |
|
Average Volume(K) |
3-Month: |
5890
|
52-Week |
High:
|
10.00 |
|
10-Days: |
2260 |
Low: |
2.15 |
|
RSI |
RSI(14):
|
49.92 |
Change(%): |
-61.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.895 |
Return on Equity (ttm) |
-137.8 |
Shares Out. (M) |
12.01 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-61.3 |
Shares Float (M) |
9.12 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.37 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.72 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.042 |
Shares Short (K) |
34 |
|
Book Value (p.s.) |
0.980 |
EBITDA (p.s.) |
-0.782 |
P/E |
-3.26 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.98 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.74 |
P/S |
701384000.00 |
|
Operating Margin |
-1881.40 |
Levered Free Cash Flow
(M) |
-6.64 |
P/CF |
-3.60 |
|
|
|
|
|
|
